Editas CMO to exit as CRISPR tech gears up; Roche diagnostics division CEO Roland Diggelmann is out
→ Roland Diggelmann is stepping down as CEO of Roche’s diagnostics division to “pursue his career outside of the company.” The Swiss drugmaker $RHHBY, which parted ways with R&D chief John Reed in recent months, has appointed Michael Heuer — the region head of Europe, Middle East, Africa, and Latin America — to fill the role ad interim. This year marks the 10th year of Diggelman’s career at Roche Diagnostics, where he previously led the Asia Pacific region.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.